
Loading, please wait...

Loading, please wait...

Circadian rhythms and lipid metabolism are deeply intertwined in human physiology. Recent research has uncovered a specific molecular conduit, HlncRNA-1, that governs hepatic circadian lipid metabolism. In India, where the prevalence of metabolic syndrome and non-alcoholic fatty liver disease is rising, understanding these pathways is crucial for developing precision interventions. This study provides a mechanistic link between the internal clock and the metabolic health of the liver.
The study identifies HlncRNA-1 as a liver-specific long non-coding RNA. This molecule responds to internal clock signals to regulate fat processing. Specifically, the protein Dhx9 occupies the HlncRNA-1 promoter. This action tethers the circadian signal to the RNA transcript. Subsequently, HlncRNA-1 recruits Hdlbp to coordinate the breakdown of lipids in the liver. Moreover, this pathway ensures that lipid catabolism aligns with the body's natural daily cycles.
Researchers observed that mice overexpressing HlncRNA-1 showed significantly less liver fat accumulation. This benefit occurred regardless of nutrient surplus or deficiency. Furthermore, these mice demonstrated improved insulin sensitivity. Consequently, activating this lncRNA could serve as a target for treating lipid disorders. Additionally, the findings are particularly relevant for individuals experiencing chronic circadian disruption. In clinical practice, this research highlights how misalignment—often caused by shift work or irregular sleep—directly impairs metabolic health.
In summary, HlncRNA-1 serves as a regulatory conduit. It translates circadian clock cues into metabolic outputs. Understanding hepatic circadian lipid metabolism allows clinicians to better appreciate the chronobiology of disease. Targeting this specific lncRNA may offer a novel approach to precisely intervene in metabolic disorders. Future therapies could focus on restoring this rhythmic control to prevent fatty liver progression.
HlncRNA-1 acts as a regulatory bridge. It translates circadian clock cues into metabolic actions, specifically controlling how the liver processes and breaks down fats during the daily cycle.
Irregular sleep patterns and night-shift work disrupt the internal clock. This misalignment can suppress protective regulators like HlncRNA-1, leading to fat accumulation, insulin resistance, and higher risk of metabolic disease.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sun C et al. HlncRNA-1 integrates the hepatic circadian clock with lipid metabolism by targeting Hdlbp. Commun Biol. 2026 May 06. doi: 10.1038/s42003-026-10178-z. PMID: 42092182.
Sinturel F, et al. Circadian rhythm of lipid metabolism. Biochem Soc Trans. 2022;50(3):1191-1204. doi: 10.1042/BST20210519.
Kumar JP, et al. Circadian rhythms in glucose and lipid metabolism in nocturnal and diurnal mammals. Mol Cell Endocrinol. 2015;418 Pt 1:74-88. doi: 10.1016/j.mce.2015.01.030.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies HlncRNA-1 as a key regulator linking the liver's circadian clock to lipid metabolism, providing insights for metabolic disease treat...
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today